{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Anaheim",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98141",
      "recalling_firm": "Preferred Pharmaceuticals, Inc.",
      "address_1": "1250 N Lakeview Ave Ste O",
      "address_2": "",
      "postal_code": "92807-1801",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Natinowide in the USA",
      "recall_number": "D-0239-2026",
      "product_description": "Ondansetron ODT Tablets, USP 4mg,  1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01",
      "product_quantity": "575 1x10 Foil Blister Packs",
      "reason_for_recall": "Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.",
      "recall_initiation_date": "20251117",
      "center_classification_date": "20251217",
      "report_date": "20251224",
      "code_info": "Lot: J1325J, I1725P, EXP Date:  4/30/2027.",
      "more_code_info": ""
    }
  ]
}